Alcoholic and nonalcoholic steatohepatitis. Histopathologic and pathogenetic considerations

被引:14
作者
Denk, H [1 ]
Stumptner, C [1 ]
Fuchsbichler, A [1 ]
Zatloukal, K [1 ]
机构
[1] Graz Univ, Inst Pathol, A-8036 Graz, Austria
来源
PATHOLOGE | 2001年 / 22卷 / 06期
关键词
alcoholic hepatitis; nonalcoholic steatohepatitis (NASH); Mallory bodies; keratins;
D O I
10.1007/s002920100489
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Alcoholic (ASH) and nonalcoholic (NASH) steatohepatitis show an almost identical morphology. Since the clinical picture is not characteristic, liver biopsy is still the diagnostic gold standard. ASH and NASH are morphologically characterized by a combination of steatosis, hepatocellular injury (ballooning degeneration, apoptosis, necrosis), perivenular and pericellular fibrosis, and inflammation (mostly neutrophils). A definitive differentiation of ASH and NASH is only possible by exclusion of alcohol abuse. Although NASH comprises a syndrome with a multifactorial etiology, adipositas seems to be the most constant associated causal factor. The pathogenesis of both diseases is still unclear. Clinical evidence and experimental studies suggest an important toxic role of reactive oxygen species (oxidative stress). According to our experience, ballooning of hepatocytes is a constant morphologic feature of ASH and NASH and already present in the early stages of disease. Ballooned cells often (but not always) contain Mallory bodies (alcoholic hyalin),which are irregular cytoplasmic inclusions consisting of keratins and nonkeratin components, including ubiquitin. Ballooning is associated with a disturbance and finally almost disappearance of the keratin-intermediate filament cytoskeleton. In our studies on the pathogenesis of ASH and NASH, we concentrated on these cytoskeletal alterations and Mallory body formation. It could be shown that in the early stages overexpression and hyperphosphorylation of keratins take place. Moreover, the 1:1 ratio of keratin type I (keratin 18) and type II (keratin 8) necessary for the assembly of intermediate filaments is disturbed and the equilibrium shifted toward keratin 8. Thus, the pool of soluble keratin 8 increases. The resulting keratin monomers are sensitive to misfolding and either degraded or aggregated as inclusion bodies. If the proteolytic capacity is impaired (e.g., by inhibition of the proteasomal system) in the chronically stressed cell aggregation prevails, finally leading to Mallory body formation. Convincing evidence exists on the basis of clinical and experimental studies that keratins exert a nonskeletal protective function in simple epithelia (e.g., liver cells). Disturbance of the keratin system may thus significantly contribute to cell damage.
引用
收藏
页码:388 / 398
页数:11
相关论文
共 68 条
[31]  
*INT GROUP, 1981, LANCET, V1, P707
[32]   ALCOHOLIC LIVER-DISEASE - PATHOLOGICAL, PATHOGENETIC AND CLINICAL ASPECTS [J].
ISHAK, KG ;
ZIMMERMAN, HJ ;
RAY, MB .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1991, 15 (01) :45-66
[33]   Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance [J].
James, OFW ;
Day, CP .
JOURNAL OF HEPATOLOGY, 1998, 29 (03) :495-501
[34]  
JENSEN K, 1994, HEPATOLOGY, V20, P1330, DOI 10.1016/0270-9139(94)90776-5
[35]   THE MALLORY BODY - MORPHOLOGICAL, CLINICAL AND EXPERIMENTAL STUDIES - LITERATURE SURVEY .1. [J].
JENSEN, K ;
GLUUD, C .
HEPATOLOGY, 1994, 20 (04) :1061-1077
[36]   Aggresomes, inclusion bodies and protein aggregation [J].
Kopito, RR .
TRENDS IN CELL BIOLOGY, 2000, 10 (12) :524-530
[37]   Keratins turn over by ubiquitination in a phosphorylation-modulated fashion [J].
Ku, NO ;
Omary, MB .
JOURNAL OF CELL BIOLOGY, 2000, 149 (03) :547-552
[38]   Mutation of human keratin 18 in association with cryptogenic cirrhosis [J].
Ku, NO ;
Wright, TL ;
Terrault, NA ;
Gish, R ;
Omary, MB .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (01) :19-23
[39]   Proteasome inhibitors: valuable new tools for cell biologists [J].
Lee, DH ;
Goldberg, AL .
TRENDS IN CELL BIOLOGY, 1998, 8 (10) :397-403
[40]   Alcoholic liver disease: new insights in pathogenesis lead to new treatments [J].
Lieber, CS .
JOURNAL OF HEPATOLOGY, 2000, 32 :113-128